Li and colleagues revealed that CCL2/CCR2-derived M1 macrophages contributed to IPF progression via manipulating myofibroblast activation by using both samples from patients and constructing a novel chemoradiation-mediated murine model. Here, CCL2 is linked to idiopathic pulmonary fibrosis.